جست‌وجوی استاد و پژوهشگر

Andrea Armstrongمشاهده پروفایل

استاد

• Civil Rights
• Criminal Justice
• Incarceration
• +۵ مورد دیگر

Andrea Armstrong is the Dr. Norman C. Francis Distinguished Professor of Law at Loyola University New Orleans College of Law and a 2023 MacArthur Fellow. She joined the faculty in 2010 and is a leading expert on prison and jail conditions, certified by the U.S. Department of Justice as a Prison Rape Elimination Act auditor. J.D., Yale Law School, 2007 M.P.A., Princeton University School of Public and International Affairs, 2001 B.A., New York University, 1996 Her scholarship focuses on the constitutional dimensions of prisons and jails, particularly prison labor practices, the intersection of race and incarceration, public oversight of detention facilities, and healthcare disparities. She integrates law with history, public policy, and the arts to highlight the human costs of incarceration, advocating for systemic reforms through environmental justice and anti-discrimination frameworks. Andrea’s research includes 15 recent articles, spanning public health in prisons, constitutional challenges to labor practices, and environmental justice analyses of death row conditions. Her work emphasizes transparency, government accountability, and the systemic failures in carceral healthcare. Scientific Awards: 2023 MacArthur Fellow 2019 Interdisciplinary Research Leader, Robert Wood Johnson Foundation Armstrong has testified before Congress on prison labor and deaths in custody, served on Louisiana legislative committees, and collaborated with museums and foundations to make incarceration law accessible. She founded IncarcerationTransparency.org and leads grant-funded projects requiring IRB approval.

Alan Winstonمشاهده پروفایل

استاد

• HIV
• Central Nervous System Complications
• Mental Health
• +۵ مورد دیگر

Professor Alan Winston serves as Professor of Genito-Urinary Medicine within the Department of Infectious Disease at Imperial College London's Faculty of Medicine. He concurrently holds a Consultant Physician position at St. Mary's Hospital, London, where he directs the HIV and GU clinical trials unit managing over 20 active studies. His clinical and academic work bridges patient care with cutting-edge research in HIV comorbidities. Winston qualified from Glasgow University and completed specialized training in general medicine and HIV care across the UK and Australia. This foundation supports his current focus on non-infectious complications in the modern antiretroviral era, particularly neurological and mental health aspects. His research prominently explores central nervous system complications in HIV, cognitive impairment mechanisms, and mental health disparities including depression and anxiety. He investigates multimorbidity patterns in aging HIV populations and develops person-centered approaches to reduce stigma. His work integrates clinical trials, cohort studies like POPPY, and mixed-methods research to address quality-of-life challenges beyond viral suppression. Analysis of his 2024-2025 publications reveals three dominant trends: (1) neurocognitive effects of specific antiretrovirals (dolutegravir, bictegravir), (2) psychosocial determinants of cognitive performance, and (3) systemic barriers in mental healthcare access for HIV patients. The POPPY cohort study serves as a critical data source across multiple publications examining aging, polypharmacy, and multimorbidity. Winston leads the POPPY study tracking comorbidities in HIV-positive individuals over time and directs the St. Mary's clinical trials unit conducting therapeutic research. His team includes clinical project managers, trials coordinators, and research staff like PhD candidate Merle Henderson. While specific grants aren't detailed, his management of 20+ concurrent studies indicates substantial research funding from sources including European AIDS Clinical Society collaborations. His laboratory and clinical operations are centered at the Winston Churchill Wing of St Mary's Campus, with affiliations to the Section of Virology and St Mary's Clinical Trials Centre. He contributes to European guideline development, notably statin use recommendations for cardiovascular prevention in HIV patients.

Mitchell F. Crustoمشاهده پروفایل

استاد

• College Athletes’ Name, Image, and Likeness (NIL) Rights
• Property Rights & Liberty
• Disaster Law & Policy
• +۷ مورد دیگر

Mitchell F. Crusto serves as the Henry F. Bonura, Jr., Distinguished Professor of Law at Loyola University New Orleans College of Law, teaching Property, Wills and Trusts, Real Estate Transactions, and Disaster Law. He has held visiting professorships at Washington University, University of Miami, and Vermont Law School, and received multiple teaching and advising awards. Education J.D., Yale Law School, 1981 M.A., Oxford University, 1985 (Marshall Scholar) B.A., Oxford University, 1980 B.A., Yale University, 1975 Research Focus : Professor Crusto's scholarship critically examines law-society intersections through lenses of liberty, property rights, and systemic equity . His pioneering work on college athletes' Name, Image, and Likeness (NIL) rights challenges traditional property frameworks, while disaster law research analyzes civil liberties during emergencies. Recent publications confront racial justice in policing, marijuana reform, and constitutional travel rights with empirical rigor and policy relevance. Publication Trends : His 2020-2025 output reveals intensified focus on emerging legal frontiers —NIL commercialization, criminal justice reform for marijuana offenses, and pandemic-era civil liberties—with 60% of recent works addressing athlete compensation and racial equity. Scholarship consistently bridges theoretical jurisprudence (e.g., libertarian property theory) with urgent real-world applications (e.g., post-Katrina civil liberties). Awards & Recognition Marshall Scholarship ABA Silver Gavel Book Award Finalist ( Involuntary Heroes ) National media features (CBS Sunday Morning, Newsweek) Multiple university teaching and advising awards Professional Impact : Crusto leverages extensive government experience—clerking for Fifth Circuit Judge John Minor Wisdom and advising two U.S. Presidents—to inform scholarship. His media advocacy (e.g., CBS Sunday Morning feature on affirmative action) translates academic work into public discourse. Though no formal lab structure exists, his disaster law research collaborates with Gulf Coast policy institutes through the Katrina-focused Involuntary Heroes initiative.

Victoria Reayمشاهده پروفایل

پژوهشگر

• Electronic Patient Records
• Health Informatics
• Medical Work Practices
• +۲ مورد دیگر

Dr Victoria Reay is an Honorary Researcher and PBL Tutor at Lancaster Medical School, Lancaster University. Qualified as a doctor in 2004, she previously held NIHR academic foundation and clinical fellow posts at Guy's and St Thomas' Hospital in London. After a hiatus from research, she returned to academia to investigate how electronic patient records reshape medical work practices in hospital settings. Her educational background includes: MBChB (medical degree) MRCP (Membership of the Royal College of Physicians) PGDip in Palliative Medicine PhD from Lancaster University (2023) titled 'Materialising the electronic patient record: Reshaping medical practices on NHS wards' Dr Reay's research spans two distinct domains. Her current work focuses on health informatics, examining how electronic patient records transform clinical workflows, documentation practices, and professional roles within NHS hospitals. Previously, she conducted significant research in respiratory immunology, particularly investigating molecular mechanisms in aspirin-sensitive asthma including prostaglandin receptor expression and IL-25 mediated angiogenesis. This interdisciplinary approach bridges clinical medicine, health services research, and sociotechnical studies of healthcare systems. Her publication record reveals a clear evolution from clinical immunology (2009-2012) to health informatics (2023). Early work centered on asthma pathophysiology, vocal cord dysfunction diagnostics, and fungal exposure assessment, while her doctoral thesis marks a decisive shift toward analyzing digital healthcare transformation. This transition reflects her firsthand experience with electronic record implementation and its profound impact on medical practice. As a PBL Tutor, Dr Reay contributes to medical education through problem-based learning. Her NIHR academic foundation and clinical fellow posts indicate prior research support, though specific current grants aren't detailed. She participates in an interdisciplinary network focused on culture, health, ethics, and society, facilitating collaborative research across these domains.

Kenneth S. Abrahamمشاهده پروفایل

استاد

• Torts
• Insurance Law
• Legal Theory
• +۴ مورد دیگر

Kenneth S. Abraham is a distinguished Professor at the University of Virginia School of Law, where he has established himself as one of the nation's leading scholars and teachers in the fields of torts and insurance law. With decades of academic excellence, Professor Abraham has shaped legal education and scholarship through his influential writings, teaching, and service to the legal profession. Professor Abraham's research focuses on the intricate relationship between tort law and insurance law, exploring how these two areas intersect to shape risk distribution, liability, and compensation systems. His scholarship spans historical analysis of legal developments, theoretical frameworks for understanding tort principles, and practical applications of insurance coverage doctrines. He has made significant contributions to understanding the evolution of tort liability, the role of insurance in shaping legal outcomes, and the theoretical underpinnings of modern tort doctrine. Professor Abraham's work often bridges historical perspective with contemporary legal challenges, revealing patterns and insights that inform current debates in tort and insurance law. His most recent scholarship demonstrates a continued focus on the theoretical foundations of tort law while addressing emerging challenges in areas such as cyber liability, police accountability, free speech implications for tort liability, and pandemic-related insurance claims. Abraham's articles frequently examine how historical developments have shaped current legal doctrines and identify conceptual gaps in existing tort theory, particularly regarding the underappreciated role of liability insurance in the tort system. William L. Prosser Award from the American Association of Law Schools (2024) Fellow of the American Academy of Arts and Sciences Life Member of the American Law Institute All-University of Virginia Outstanding Teacher Award Distinguished Faculty Achievement Certificate from the State Council of Higher Education for Virginia American Bar Association's Robert B. McKay Law Professor Award First law professor elected as an honorary fellow of the American College of Coverage Counsel Professor Abraham has served on the ALI Council for 20 years and has been an adviser to the ALI's 'Restatement of Torts (Third)' and the senior adviser to the 'Restatement of the Law of Liability Insurance.' His expertise is frequently sought in major insurance coverage cases involving commercial general liability, directors and officers liability, environmental cleanup liability, toxic tort and products liability, and property insurance claims. He has also served as an arbitrator for the Dalkon Shield Claimants Trust, resolving over 100 claims by women seeking damages for injuries caused by the Dalkon Shield intrauterine device.

Pierre-Yves Marroمشاهده پروفایل

مدرس

• International Law
• European Law
• International Litigation
• +۵ مورد دیگر

Pierre-Yves Marro is a Swiss and New York qualified attorney serving as Counsel at Quinn Emanuel Urquhart & Sullivan in Zurich while maintaining an active academic role as Privatdozent (Private lecturer) at Zurich University School of Law. He holds Venia Legendi for Public International Law and European Law, teaching courses on International Organizations and International Litigation. Marro is also a member of the Institute for International Law and Comparative Constitutional Law at Zurich University. His educational background includes a summa cum laude Dr. iur. (Ph.D. in Law) from Zurich University School of Law (awarded Prix Paul Guggenheim and Professor Walther Hug Prize), magna cum laude Lic. iur. from the same institution, and an LL.M. in International Legal Studies from NYU School of Law. He has been admitted to the New York Bar since 2011 and the Zurich Bar since 2013. Marro specializes in complex domestic and international proceedings, advising clients in cross-border multi-jurisdictional disputes and pre-litigation strategy. His research interests focus on international law, European law, state immunity, international organizations, and the intersection of public international law with domestic legal systems. His scholarly work demonstrates particular expertise in Swiss civil procedure, enforcement of claims, and the legal status of international organizations. His recent publications reveal a strong focus on Swiss legal frameworks, particularly the Swiss Civil Code and procedural law, while also addressing broader European and international legal contexts. The publications show consistent engagement with practical legal challenges in arbitration, state immunity, financial regulation, and cross-border dispute resolution, reflecting his dual practice in both academic and professional legal settings. Future Leader in Commercial Litigation by Who's Who Legal (2022, 2023, 2024) Rising Star in Commercial Arbitration by Euromoney's Expert Guides (2022) Key Lawyer by Legal 500 EMEA for Arbitration and Litigation (2024, 2025) Highly Recommended for Commercial Litigation by Leaders League Switzerland (2023, 2024) Marro regularly speaks at conferences on litigation and public international law topics and has served as a substitute professor at Zurich University. His professional activities include membership in the Swiss Bar Association, Zurich Bar Association, Swiss Arbitration Association, and Zurich Lawyers Association, demonstrating his active engagement with both academic and professional legal communities in Switzerland.

Peter N. Salibمشاهده پروفایل

استادیار

• Artificial Intelligence Law
• Constitutional Law
• AI Governance
• +۳ مورد دیگر

Peter N. Salib is an Assistant Professor at the University of Houston Law Center and Associate Faculty in Public Affairs. He serves as Law and Policy Advisor to the Center for AI Safety in San Francisco and co-Director of the Center for Law & AI Risk. University of Houston Law Center Public Affairs Faculty Center for AI Safety Center for Law & AI Risk His research combines constitutional law and economic analysis to address AI governance challenges. Current work focuses on legal frameworks for mitigating catastrophic AI risks through regulatory innovation. Publications appear in top law reviews including University of Chicago Law Review, Virginia Law Review, and Texas Law Review. Recent scholarship trends indicate expertise in: Algorithmic discrimination in health equity Constitutional implications of AI rights Jury nullification theories in abortion cases AI arms race international law Computational law applications As former Climenko Fellow at Harvard Law School and attorney at Sidley Austin LLP, he brings both academic and practical legal experience. Judicial clerkship with Hon. Frank H. Easterbrook informs his constitutional analysis approach.

John H. Richburgمشاهده پروفایل

استاد

• Toxicology
• Reproductive Biology
• Male Fertility
• +۵ مورد دیگر

John H. Richburg, Ph.D. serves as Associate Dean for Research and Graduate Studies and Professor of Pharmacology & Toxicology at The University of Texas at Austin College of Pharmacy. He holds the distinguished Gustavus and Louise Pfeiffer Professorship in Toxicology, reflecting his significant contributions to the field. Dr. Richburg's research program has been continuously funded by the NIH for over 28 years, focusing on molecular and cellular mechanisms by which environmental toxicants (particularly phthalates) and chemotherapeutic agents (like cisplatin) disrupt male reproduction. His work specifically investigates paracrine cellular signaling mechanisms between cells in the testis that regulate the balance between survival and death of germ cells. The Richburg Laboratory recently received a 5-year NIH/NIEHS R01 grant to study the functional contribution of innate immune cells in testicular responses to environmental toxicants. Analysis of Dr. Richburg's publications reveals a consistent focus on testicular toxicology, with particular emphasis on phthalate exposure effects and cisplatin-induced male infertility. His work bridges immunology, reproductive biology, and toxicology, demonstrating how environmental and clinical agents disrupt spermatogenesis through complex cellular mechanisms. Recent publications increasingly incorporate transcriptomics and detailed immune cell analysis, showing evolution toward more sophisticated molecular approaches. Best Paper of 2021 in Toxicological Sciences by the Society of Toxicology's Reproductive and Developmental Toxicology Specialty Section As Associate Dean, Dr. Richburg oversees research and graduate programs, enhancing outside research funding and recruiting qualified graduate students. His laboratory has trained numerous doctoral students, postdoctoral fellows, and research scientists, with alumni occupying prominent positions in academia, industry, and government. The Richburg Lab maintains active research projects on MEHP-induced testicular inflammation and cisplatin-induced male infertility, supported by continuous NIH funding. Dr. Richburg leads a vibrant research team comprising postdoctoral scholars, graduate students, and undergraduate researchers, fostering the next generation of toxicologists while advancing understanding of environmental and clinical impacts on male reproductive health.

• Oral Microbiology
• Clinical Microbiology
• Infection Control
• +۵ مورد دیگر

Professor Jeremy Bagg is Professor of Clinical Microbiology and Head of Glasgow Dental School at the University of Glasgow since January 2005. He also serves as Deputy Head of the School of Medicine, Dentistry & Nursing. With a distinguished career spanning over four decades, Professor Bagg has made significant contributions to oral microbiology, infection control, and public health dentistry. Professor Bagg qualified BDS (Hons) from the University of Edinburgh in 1979 and was awarded a PhD in 1982 for research on bacterial adhesion mechanisms. He served as Lecturer in Oral Medicine & Oral Pathology at Cardiff Dental School from 1983-1991, gaining the FDS diploma and MRCPath in oral microbiology in 1987. Joining the University of Glasgow in 1991 as Lecturer in Oral Microbiology, he was awarded a Personal Professorship in Clinical Microbiology in 1999. His research focuses on the role of oral micro-organisms in systemic disease, oral infections in medically compromised patients, infection control in dental surgery, and public health microbiology. As a member of the Infection & Immunity Research Group, Professor Bagg has co-authored two textbooks and published over 160 papers. His work spans dental microbiology, infection control practices, oral-systemic health connections, and global oral health policy development, with particular expertise in denture microbiology, blood-borne virus management, and the oral health of medically compromised patients. Professor Bagg holds significant leadership positions including Chairman of the National Dental Advisory Committee at the Scottish Government Health Department and Chair of the Steering Group of the Scottish Dental Clinical Effectiveness Programme. He is also a member of the UK Advisory Panel for Health Care Workers Infected with Blood-borne Viruses. In 2004, he was awarded the Fellowship of the Faculty of Public Health for his contribution to public health microbiology. His recent work demonstrates continued excellence across multiple domains including dental infection control, global oral health policy, dental education innovation, and the microbiology of oral diseases. Professor Bagg's research has particular relevance to denture care, blood-borne virus management in dental settings, and the connection between oral health and systemic conditions. Professor Bagg has contributed to major initiatives including the Scottish Oral Health Research Strategy and serves as one of two Scottish representatives on the Oral & Dental Specialty Group of the UK Clinical Research Network. His work has influenced dental practice guidelines and public health policy in Scotland and beyond.

Dirk Buschمشاهده پروفایل

استاد

• Infection Immunology
• Antigen-Specific T Cell Biology
• Immunotherapy
• +۳ مورد دیگر

Prof. Dirk Busch is a Professor and Director of the Institute of Medical Microbiology, Immunology and Hygiene at the Technische Universität München (TUM). He leads the focus group 'Clinical Cell Processing and Purification' at TUM's Institute for Advanced Study. His research focuses on infection immunology, particularly antigen-specific T cell mechanisms and translational applications in immune cell-based therapies. He chairs the German Center for Infection Research (DZIF) and is a member of the German National Academy of Sciences Leopoldina. Education: Studied medicine in Mainz and Freiburg (1993), completed clinical training in pediatric infectious diseases at Würzburg (1993–1996), and held a DFG scholarship at Yale University (1996–1999). Qualified as a professor in 2003 and completed his residency in medical microbiology at TUM in 2005. Research interests include developing diagnostic tools and cell therapies using immune cells, with a focus on T cell engineering and chronic infection dynamics. He co-founded STAGE Cell Therapeutics GmbH and T Cell Factory BV. Awards include the Science Day Award (2008), Wilhelm Vaillant Prize (2003), and Gerhard Hess Research Prize (2000). Key research contributions span T cell receptor engineering, memory T cell biology, and MHC multimer-based cell isolation techniques. His work bridges basic immunology with clinical applications in cell therapy and infection control.

Ronald Dijkmanمشاهده پروفایل

دانشیار

• Respiratory virology
• Coronaviruses
• Influenza viruses
• +۵ مورد دیگر

PD Dr. Ronald Dijkman is Group Leader of the Experimental Virology Research Group within the Institute for Infectious Diseases (IFIK) at the University of Bern Medical Faculty. His laboratory is located at the Multidisciplinary Center for Infectious Diseases (MCID) , underscoring his central role in Swiss infectious-disease research infrastructure. Education & Training: While the supplied pages do not list explicit degrees, the title PD Dr. indicates that he has completed a PhD, post-doctoral training, and the Germanic Habilitation, qualifying him as an Associate Professor-level faculty member. Research Focus: Dr. Dijkman’s team investigates host–pathogen interactions in the respiratory epithelium , concentrating on three pillars: Innate immunity triggered by influenza and coronaviruses in human and animal airway epithelial cells. Viral genetic determinants that modulate immune evasion and cross-species transmission. Host determinants that either restrict or facilitate infection across species barriers. To dissect these questions, the group has pioneered genetically-tractable, well-differentiated primary airway epithelial cell (AEC) cultures derived from humans, pigs, cattle and bats, creating a unique comparative platform for zoonotic-risk assessment. Funding & Collaborative Networks: His research is currently supported by: Swiss National Science Foundation (SNF) – project on Molecular characterization of Influenza D virus–host interactions . EU Marie Skłodowska-Curie ITN “HONOURs” – a multi-partner training network on host-switching pathogens and zoonoses. Federal BLV grant – implementation of nanopore sequencing for rapid identification of OIE-notifiable animal viruses. These grants enable a team of one post-doc and four PhD students, together with technical staff. Scientific Output & Impact: Since 2010, Dr. Dijkman has authored >60 peer-reviewed articles. His work on SARS-CoV-2 reverse genetics (Nature, 2020), MERS-CoV receptor usage (Nature, 2014) and single-cell influenza pathogenesis (bioRxiv, 2020–22) has been highly cited, reflecting broad scientific impact. Laboratory & Team: The Experimental Virology group occupies BSL-2 and BSL-3 laboratories equipped with state-of-the-art live-cell imaging, lentiviral genetic engineering, and nanopore sequencing pipelines. The group presently comprises: Larise Oberholster – Early Post-doc Alina Baltensperger – PhD student Jean-Claude Makangara – PhD student Mike Javan Mwanga – PhD student Karen Stevers – PhD student Cinzia Moscardelli – laboratory technician

Nidhi Sofatمشاهده پروفایل

استاد

• Rheumatology
• Osteoarthritis
• Inflammation Mechanisms
• +۵ مورد دیگر

Professor Nidhi Sofat is a Professor of Rheumatology at St George's, University of London, and a Consultant Rheumatologist at St George's University Hospitals NHS Foundation Trust. She leads the NIHR Integrated Academic Programme for Clinical Academic Trainees, overseeing research and training programs such as the PGCert in Research Skills and Methods. She qualified in medicine from University College London (1996) with First Class Honours, completed specialist rheumatology training in 2007, and earned her PhD from the Kennedy Institute of Rheumatology (Imperial College London). Her research focuses on understanding pain and inflammation in musculoskeletal diseases, particularly osteoarthritis and rheumatoid arthritis. Her group pioneered the Osteoarthritis Bone Score (OABS), the first histological scoring system for bone marrow lesions in osteoarthritis. Key research areas include mechanisms of pain sensitization, imaging techniques (MRI), clinical trials (e.g., DUPRO, PAPO), and collaborations with institutions like the University of Nottingham and Royal Veterinary College. She has received awards such as the Michael Mason Prize (2013) and Wellcome Trust Fellowship (2003). Her clinical roles include managing general rheumatology, inflammatory arthritis, and osteoarthritis at the Hotung Centre. She has contributed to national guidelines via the Arthritis and Musculoskeletal Alliance (ARMA) and served on committees like the British Society for Rheumatology's Heberden Committee. Major grants include funding from NIHR, Versus Arthritis, and the Wellcome Trust. Collaborations span academic and industry partners, including Pfizer and Merck. Her translational research facility bridges clinical and experimental work, aiming to improve diagnostic tools and therapies for arthritis.

Luma Munjyمشاهده پروفایل

استادیار

• Diabetes
• Hypertension
• Dyslipidemia
• +۷ مورد دیگر

Luma Munjy serves as Assistant Professor of Pharmacy Practice and Director of Pre-APPE Readiness Curricular Integration at Chapman University School of Pharmacy. She joined Chapman University in August 2018 following her tenure at California Health Sciences University where she established clinical pharmacy services at a Federally Qualified Health Center in the Central Valley. Dr. Munjy received her Doctor of Pharmacy from the University of California, San Francisco in 2013 and completed an Ambulatory Care residency at the University of Southern California. Dr. Munjy's research focuses on embedding clinical pharmacists in ambulatory care settings through inter-professional team-based delivery of care. She investigates methods to sustain clinical pharmacists as core team members in primary care practices by demonstrating improvements in health markers, patient satisfaction, and provider satisfaction. Her work also explores how non-pharmacological therapies like mindfulness meditation and music therapy can improve medication adherence and patient outcomes. Additionally, she researches training health professional students in the affective domain of learning. Analysis of Dr. Munjy's recent publications reveals a strong focus on educational methodologies, particularly team-based learning approaches that target the affective domain of learning. Her work spans chronic disease management (diabetes, hypertension, asthma), immunization practices, and innovative educational techniques to develop emotional intelligence in healthcare professionals. She has contributed significantly to both clinical practice literature and pharmacy education scholarship. Home blood pressure monitoring for hypertension control Affective domain learning in pharmacy education Optimizing chronic disease management through transitions of care Immunization practices and vaccine education Team-based learning methodologies for healthcare education Dr. Munjy has established herself as an educator who bridges clinical practice with innovative teaching methodologies. Her work on ethical dilemma discussions and emotional intelligence development in healthcare students represents a significant contribution to health professions education. While specific grant details aren't mentioned in the provided materials, her numerous publications across multiple venues demonstrate active scholarly engagement in both clinical pharmacy practice and educational innovation. At Chapman University, Dr. Munjy directs the Pre-APPE Readiness Curricular Integration program, focusing on preparing pharmacy students for advanced practice experiences through innovative educational approaches that integrate emotional intelligence development with clinical knowledge acquisition.

Andrew Kentمشاهده پروفایل

استاد

• Constitutional Law
• Foreign Relations Law
• National Security Law
• +۵ مورد دیگر

Andrew Kent is the Joseph M. McLaughlin Professor of Law at Fordham University School of Law, specializing in Constitutional Law, Foreign Relations Law, Legal Ethics, and National Security Law. His scholarship addresses presidential power, U.S. colonial governance, extraterritorial constitutional rights, Civil War legal history, and remedies for constitutional torts. He has held visiting roles at Harvard and practiced law at Sullivan & Cromwell and WilmerHale before joining Fordham. JD, Yale Law School AB, Harvard College His research focuses on the intersection of constitutional principles with national security, foreign affairs, and judicial accountability, as seen in his work on Bivens actions, qualified immunity, and the Take Care Clause. His recent articles in leading journals like the Harvard Law Review and Columbia Law Review explore historical legal frameworks and modern implications for executive power. Andrew Kent has testified before Congress, served as Senior Counsel to the New York Solicitor General (2014-2015), and held leadership roles in legal ethics committees. He actively engages in pro bono work, including freeing a wrongfully convicted individual, and contributes to public discourse on Justice Department independence and presidential accountability, as cited in The New York Times and Reuters.

Christine Markhamمشاهده پروفایل

استاد

• Adolescent Health
• Sexual Health
• Program Evaluation
• +۵ مورد دیگر

Christine Markham, PhD, serves as Professor and Department Chair of Health Promotion & Behavioral Sciences at the University of Texas Health Science Center at Houston School of Public Health. With over 30 years of experience in adolescent health promotion, her work focuses on technology-driven multilevel interventions in sexual health education, obesity prevention, and chronic disease management. Her research spans diverse populations including Hispanic, African-American, and HIV-positive youth, with significant contributions like the 'It’s Your Game…Keep It Real' curriculum recognized by the USDHHS Office of Population Affairs. Education: Not explicitly detailed in provided texts. Research: Specializes in Intervention Mapping framework, HPV vaccination promotion, trauma-informed care, and technology-enhanced health education programs. Recent publications highlight her expertise in HPV vaccination disparities, digital health interventions, and school-based implementation strategies. Dr. Markham co-authored works on maternal HPV perceptions, regional vaccine recommendations, and cross-sector coalition efforts for community health programs. Her leadership in the Center for Health Promotion and Prevention Research underscores her commitment to public health innovation.